Evidence map›Paper›PMID 22515424›Full record

ArticleBMC pediatrics2012

Pharmacokinetics and pharmacodynamics of medication in asphyxiated newborns during controlled hypothermia. The PharmaCool multicenter study.

Timo R de Haan, Yuma A Bijleveld, Johanna H van der Lee, Floris Groenendaal, Marcel P H van den Broek, Carin M A Rademaker, Henrica L M van Straaten, Mirjam M van Weissenbruch, Jeroen R Vermeulen, Peter H Dijk and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Observational
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 1 country.

Timo R de HaanDepartment of Neonatology, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands. t.r.dehaan@amc.uva.nl
Yuma A Bijleveld
Johanna H van der Lee
Floris Groenendaal
Marcel P H van den Broek
Carin M A Rademaker
Henrica L M van Straaten
Mirjam M van Weissenbruch
Jeroen R Vermeulen
Peter H Dijk
Jeroen Dudink
Monique Rijken
Arno van Heijst
Koen P Dijkman
Danilo Gavilanes
Anton H van Kaam
Martin Offringa
Ron A A Mathôt
Academic Medical Center · NLUniversity of Amsterdam · NLUniversity Medical Center Utrecht · NLAmsterdam Neuroscience · NLAmsterdam UMC Location VUmc · NLErasmus MC - Sophia Children’s Hospital · NLIsala · NLLeiden University Medical Center · NLMaastricht University · NLMáxima Medisch Centrum · NLRadboud University Nijmegen · NLUniversity Medical Center Groningen · NLWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the Netherlands, perinatal asphyxia (severe perinatal oxygen shortage) necessitating newborn resuscitation occurs in at least 200 of the 180-185.000 newly born infants per year. International randomized controlled trials have demonstrated an improved neurological outcome with therapeutic hypothermia. During hypothermia neonates receive sedative, analgesic, anti-epileptic and antibiotic drugs. So far little information is available how the pharmacokinetics (PK) and pharmacodynamics (PD) of these drugs are influenced by post resuscitation multi organ failure and the metabolic effects of the cooling treatment itself. As a result, evidence based dosing guidelines are lacking. This multicenter observational cohort study was designed to answer the question how hypothermia influences the distribution, metabolism and elimination of commonly used drugs in neonatal intensive care. METHODS/

designMulticenter cohort study. All term neonates treated with hypothermia for Hypoxic Ischemic Encephalopathy (HIE) resulting from perinatal asphyxia in all ten Dutch Neonatal Intensive Care Units (NICUs) will be eligible for this study. During hypothermia and rewarming blood samples will be taken from indwelling catheters to investigate blood concentrations of several antibiotics, analgesics, sedatives and anti-epileptic drugs. For each individual drug the population PK will be characterized using Nonlinear Mixed Effects Modelling (NONMEM). It will be investigated how clearance and volume of distribution are influenced by hypothermia also taking maturation of neonate into account. Similarly, integrated PK-PD models will be developed relating the time course of drug concentration to pharmacodynamic parameters such as successful seizure treatment; pain assessment and infection clearance. DISCUSSION: On basis of the derived population PK-PD models dosing guidelines will be developed for the application of drugs during neonatal hypothermia treatment. The results of this study will lead to an evidence based drug treatment of hypothermic neonatal patients. Results will be published in a national web based evidence based paediatric formulary, peer reviewed journals and international paediatric drug references.

trial registrationNTR2529.

Indexed as

Hypothermia, InducedResuscitationAsphyxia NeonatorumChromatography, LiquidClinical ProtocolsCohort StudiesElectroencephalographyFemaleHumansHypoxia-Ischemia, BrainInfant, NewbornIntensive Care, NeonatalIntensive Care Units, NeonatalMaleMass SpectrometryPharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID22515424
PMCPMC3358232
OpenAlexW2103184465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.